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Introduction
Florid diabetic retinopathy (FDR) is a term usually applied to a 
particularly aggressive, bilateral proliferative diabetic retinopathy. 
It is a difficult condition to manage, with the patient often ending 
up with blindness over a course of  time despite treatment. Here 
in, we report a young patient with FDR who refused intra-vitreal 
injections, but was successfully managed by an appropriate 
utilization of  laser photocoagulation, orbital floor steroid 
injections and vitreo-retinal surgery.
Materials and Methods
7 years back a 21-year old unmarried, non-obese female patient 
was referred to us for diabetic retinopathy screening. She was on 
oral metformin (100mg once daily) and oral gliclazide (80mg twice 
daily). Her blood glucose level was consistently maintained at 
72-90mg/dl. No systemic abnormalities, including nephropathy, 
were detected. 
The patient had no ocular symptoms and her best corrected visual 
acuity was 6/18 in both eyes. The anterior segments in both eyes 
were normal. However, fundus examination showed profuse 
florid diabetic retinopathy, with “coralliform” vessels branching 
out from the optic disc vessels. Areas of  neovascularisation else 
where (NVE) were also visible. Clinically significant macular 
edema (CSME) was prominently present in both eyes (Figure 1, 
2).
The patient underwent multiple sessions of  grid and pan-
retinal photocoagulation, augmented initially with orbital floor 
triamcinolone acetonide injection, as the patient refused any intra-
vitreal injections. After a period of  time, the condition dampened 
appreciably. The FDR and CSME regressed and the BCVA 
improved to 6/10 in both eyes. After a period of  nearly 1 year 
the patient started to develop vitreous hemorrhage in the left eye. 
She was advised for a vitrectomy which she continued to refuse. 
Ultimately, nearly 3 years after being seen here she underwent a 
vitrectomy with endolaser and silicon oil injection. Subsequently, 
the condition resolved appreciably with a small area of  residual 
fibrosis remaining and the patient regaining good vision which is 
maintained over 4 years of  follow-up. On the last visit, 3 months 
back her BCVA was 6/9 in the right eye and 6/15 in the left eye 
(Figure 3-6).
Abstract
Florid diabetic retinopathy is an unusual, aggressive type of  diabetic retinopathy. It is seen in young patients with poor 
metabolic control. Despite advances in treatment the overall prognosis of  this condition remains poor. A 21-year old 
female patient was seen by us and found to have florid diabetic retinopathy despite an adequate metabolic control by oral 
hypoglycemic agents. The patient underwent multiple laser and orbital floor triamcinolone acetonide injections. Later the 
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year follow-up she has shown a visually and anatomical stable response. 
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Results and Discussions
Florid diabetic retinopathy (FDR) is a term used by Kohner and 
Oakley to describe a severe, bilateral, rapidly progressive type of  
proliferative diabetic retinopathy occurring in young adults [1]. 
FDR is characterized by its occurrence in Type I diabetic patients 
who are less than 40 years of  age and who show a progression 
to proliferative diabetic retinopathy in less than 6 months [2]. 
Beaumont and Hallows have described FDR as a “rapid, bleeding 
and blinding” condition [3]. The pathogenesis of  FDR is likely due 
to diffuse retinal ischemia with breakdown of  the blood-retinal-
barrier in widespread areas of  the retina. Kitano has shown that 
acute hypoglycemic episodes along with transient increases in the 
serum levels of  insulin-like growth factor 1 (IGF-1) and vitreous 
levels of  vascular endothelial growth factor (VEGF) contribute to 
the development of  FDR [4]. 
Figure 1. Right eye of  the patient on initial presentation.
Figure 2. Left eye of  the patient on initial presentation.
Figure 3. Right eye of  patient after initial treatment.
Figure 4. Left eye of  patient after initial treatment.
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Figure 5. Right eye of  patient on last review.
Figuer 6. Left eye of  patient following vitrectomy.
Poor long-term metabolic control of  diabetes is found to be a 
significant finding in patients with FDR. The HbA1c levels should 
be monitored and kept within normal target range [5]. FDR is also 
reported to regress with the usage of  an insulin-infusion device 
[6] and also with continuous subcutaneous insulin infusion [7]. 
Curiously, in our patient however, the metabolic control was 
persistently good. Associated hypertension in patients having 
FDR is another risk factor [8].
FDR is characterized by a rapid progression from moderate 
non-proliferative diabetic retinopathy to florid, aggressive 
neovascularisation over the disc and elsewhere. Devastating 
complications can develop over a period of  weeks, underlining 
the importance of  frequent, close follow-up of  the patients.
[8]. Major complications which can lead to blindness include: 
Tractional retinal detachment, neovascular glaucoma and anterior 
hyaloidal fibrovascular proliferation (AHFP) [2, 9]. In a study 
of  FDR, Lattanzio et al., divided patients into two groups 
depending on their baseline retinal condition and feasibility of  
photocoagulation: group 1 included eyes which were amenable to 
laser photocoagulation and if  required, subsequent vitreoretinal 
surgery; whereas group 2 consisted of  eyes with more advanced 
diabetic retinopathy, requiring primary vitreo retinal surgery and 
laser photocoagulation. After a follow-up of  54 months, 75% 
of  eyes in group 1 were found to have a favorable anatomical 
outcome with a resultant mean final visual acuity of  0.47. In 
group 2, diabetic retinopathy progressed in 68% of  eyes and a 
mean final visual acuity of  0.14 could be achieved. The latter 
group also had 6 times higher rates of  blindness as compared 
to group 1 (31% versus 5%). The authors suggested that early 
diagnosis and treatment can halt the progression of  FDR in three 
out of  four cases [8].
In a 17-year old girl with FDR and Donahue syndrome, Casati et 
al., achieved satisfactory regression of  NVD and maintenance of  
good visual acuity following PRP [10]. However, Seyer-Hansen 
reported complete blindness in a 22-year old patient within 30 
months of  diagnosis of  diabetes mellitus [11]. If  left untreated, 
FDR can lead to blindness over a period of  2-4 years [5]. In 
our patient, satisfactory vision was achieved by judicious use of  
medical and surgical techniques to manage the condition.
According to Agardh, PRP should be instituted early, once the 
stage of  severe non-proliferative diabetic retinopathy is detected 
[5]. However, vitreo-retinal surgery might be required in cases 
having tractional RD involving or threatening the macula, 
combined tractional and rhegmatogenous RD, rapid onset of  
fibrovascular proliferations (FVP) despite PRP with or without 
extramacular tractional RD, vitreous hemorrhage without 
spontaneous clearing, or recurrent vitreous hemorrhage [2]. In 
these cases, preoperative intravitreal injections of  anti-VEGF 
agents have been found to be particularly beneficial. These agents 
facilitate the dissection of  proliferative fibrovascular membranes, 
reduce intraoperative bleeding as well as postoperative AFVP [2]. 
Conclusion
While FDR is a condition fraught with a grave prognosis, yet it 
is possible to achieve a favorable response by the utilization of  
grid/focal and pan-retinal photocoagulation, orbital floor steroid 
injections and vitreo-retinal surgery.
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